BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s10637-014-0163-9
Published Online: 2014-10-25
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ku, Bo Mi
Jho, Eun Hye
Bae, Yeon-Hee
Sun, Jong-Mu
Ahn, Jin Seok
Park, Keunchil
Ahn, Myung-Ju
Text and Data Mining valid from 2014-10-25
Version of Record valid from 2014-10-25
Article History
Received: 22 July 2014
Accepted: 15 September 2014
First Online: 25 October 2014